Metabolically healthy obesity: Is there a link with PUFA intake and status?
The aim of this study was to compare dietary intake and status of polyunsaturated fatty acids (PUFA) in plasma and erythrocyte phospholipids metabolically healthy-and unhealthy, obese and non-obese persons. Metabolic health status in 171 participants was defined according to criteria for metabolic syndrome. Obese and non-obese metabolically unhealthy persons (MUHO and MUHNO) had higher energy intake of n-6 PUFA (7.82±1.03 and 7.49±0.86), and lower intake of n-3 PUFA (0.60±0.12 and 0.62±0.11) compared to obese and non-obese metabolically healthy persons (MHO and MHNO) (5.92±0.63 and 5.72±0.67; 1.20±0.07 and 1.22±0.09, respectively), and higher n-6/n-3 PUFA ratio. Plasma level of n-6 PUFA was lower in MUHO and MUHNO groups (38.49±3.71 and 38.53±2.19) compared to MHNO (40.90±2.43), while n-3 PUFA status was lower in obese than in non-obese persons (3.58±0.79 and 3.50±1.02 vs 4.21± 0.80 and 4.06±1.15). MHO group had higher eicosapentaenoic/arachidonic acid ratio and estimated desaturase (SCD16, D6D) and elongase activity in plasma phospholipids compared to MHNO. Low intake of n-3 PUFA is directly associated with metabolic risk factors. These results indicated that obesity is closely associated with low levels of n-3 PUFA in plasma phospholipids, suggesting that dietary modifications including n-3 PUFA supplementation appear to be suitable therapeutic strategy in obese persons.